Improved PeptidesImproved Peptides is a United States–based supplier of research-grade peptides, operated by The Improved Company LLC. It supplies lyophilized research peptides — including widely studied compounds such as BPC-157, TB-500, GHK-Cu, Semax, Selank, and Epitalon — strictly for laboratory research use only. Every batch undergoes independent third-party analysis, including HPLC purity testing and mass-spectrometry identity confirmation, and ships with a batch-specific Certificate of Analysis that is publicly accessible. The company's positioning, "The Improved Standard," reflects a focus on verifiable testing transparency and traceability. Improved Peptides products are not drugs, supplements, or foods, and are not for human or animal consumption.
Improved Peptides (improvedpeptides.com) has 2 customer reviews on Five Star Index, with an average rating of 5.0 out of 5.
Is this your business?
Correct your details and reply to customers in public. Both are free.
Claim this listing2 approved reviews, newest moderated first
Grace O.
I had a really good experience with IP and can’t wait to order again. They had a wide range of products and had really helpful support!
Response from Improved PeptidesMay 28, 2026
Really appreciate the support. Glad you had a great experience with us and that our team could help along the way. Looking forward to serving you again soon.
Tanner G.
Found them off Reddit. Wanted a company that had a premium product. Everything was great, got my order in 3 days(typical for a peptide company). Their prices can be on the higher side, but I trust the quality and don’t like to shop cheap for peps.
Response from Improved PeptidesMay 28, 2026
Really appreciate this. We know we’re not the cheapest option out there, and that’s intentional. We’d rather focus on verified quality, fast shipping, and a premium experience from start to finish than cut corners to compete on price alone. Glad everything landed quickly and lived up to expectations, appreciate you trusting us with your research needs.
